Role of pharmacokinetics in the development of medicinal products in the paediatric population

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/EWP/147013/2004
Published28/06/2006
Effective from01/01/2007
KeywordsChildren, extrapolation, dose finding, maturation, age
DescriptionThis document provides advice on the use of pharmacokinetic studies in paediatric drug development. It also covers methodological issues concerning pharmacokinetic studies in paediatric patients.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more